心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2018 CHEST指南：房颤抗栓治疗

2018-08-21 美国胸科医师学会 Chest. 2018 Aug 21.

房颤抗栓治疗

2018年8月，CHEST发布最新版房颤抗栓治疗指南。不同类型房颤患者卒中风险各异，依据各种卒中危险因素，本文主要针对房颤患者的抗栓治疗提出指导意见。

中文标题：

2018 CHEST指南：房颤抗栓治疗

英文标题：

Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.

发布机构：

美国胸科医师学会

发布日期：

2018-08-21

简要介绍：

2018年8月，CHEST发布最新版房颤抗栓治疗指南。不同类型房颤患者卒中风险各异，依据各种卒中危险因素，本文主要针对房颤患者的抗栓治疗提出指导意见。 

拓展指南：与房颤相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 CHEST指南：房颤抗栓治疗)] GetToolGuiderByIdResponse(projectId=1, id=928cf1c001632ebd, title=2018 CHEST指南：房颤抗栓治疗, enTitle=Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report., guiderFrom=Chest. 2018 Aug 21., authorId=null, author=, summary=2018年8月，CHEST发布最新版房颤抗栓治疗指南。不同类型房颤患者卒中风险各异，依据各种卒中危险因素，本文主要针对房颤患者的抗栓治疗提出指导意见。 , cover=, journalId=null, articlesId=null, associationId=180, associationName=美国胸科医师学会, associationIntro=提供胸科疾病指南, 《chest》是美国胸科医师学会旗下期刊。, copyright=0, guiderPublishedTime=Tue Aug 21 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年8月，CHEST发布最新版房颤抗栓治疗指南。不同类型房颤患者卒中风险各异，依据各种卒中危险因素，本文主要针对房颤患者的抗栓治疗提出指导意见。 </div> <div><br> </div> 拓展指南：<strong>与<font color=red>房颤</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=928cf1c001632ebd" title="2018 CHEST指南：房颤抗栓治疗" target=_blank>2018 CHEST指南：房颤抗栓治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=98f841c00162a09b" title="2018 NHFA/CSANZ临床指南：心房颤动的诊断和管理" target=_blank>2018 NHFA/CSANZ临床指南：心房颤动的诊断和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c35121c00162226a" title="2018 欧洲联合共识声明：房颤患者表现为急性冠脉综合征和/或经皮心血管介入治疗的抗栓治疗管理" target=_blank>2018 欧洲联合共识声明：房颤患者表现为急性冠脉综合征和/或经皮心血管介入治疗的抗栓治疗管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=445b61c0015e2325" title="2018 EHRA实践指导：房颤患者应用非维生素K拮抗剂口服抗凝药" target=_blank>2018 EHRA实践指导：房颤患者应用非维生素K拮抗剂口服抗凝药</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=239281c00151e6c5" title="2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗" target=_blank>2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E6%88%BF%E9%A2%A4" target=_blank>有关房颤更多指南</a></ul>, tagList=[TagDto(tagId=364, tagName=房颤), TagDto(tagId=3301, tagName=抗栓治疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12251, appHits=1469, showAppHits=11, pcHits=8763, showPcHits=3167, likes=179, shares=53, comments=6, approvalStatus=1, publishedTime=Tue Aug 28 20:30:45 CST 2018, publishedTimeString=2018-08-21, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Aug 28 20:30:45 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:01:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 CHEST指南：房颤抗栓治疗)])
2018 CHEST指南：房颤抗栓治疗
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057560, encodeId=d642105e56034, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:58 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353072, encodeId=13083530e24d, content=请问有中文版的吗？中文版的哪里可以找得到呢？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95442486909, createdName=1246deccm12暂无昵称, createdTime=Mon Nov 19 19:25:40 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352547, encodeId=997135254ea9, content=非常不错的临床经验，值得借鉴与推广，学习了，受益匪浅，谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/27/c53a212859edcad4f60a54feffff50bb.jpg, createdBy=67cf1525321, createdName=13718711b3m, createdTime=Wed Nov 14 09:38:38 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345000, encodeId=b2e834500090, content=Thank foryou , beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/5c6d9ad84d8af7c9d20340af15a39b5a.jpg, createdBy=9a732240675, createdName=徐小坏, createdTime=Fri Sep 14 21:10:16 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341573, encodeId=7add3415e3fb, content=谢谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Aug 29 07:38:56 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057560, encodeId=d642105e56034, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:58 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353072, encodeId=13083530e24d, content=请问有中文版的吗？中文版的哪里可以找得到呢？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95442486909, createdName=1246deccm12暂无昵称, createdTime=Mon Nov 19 19:25:40 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352547, encodeId=997135254ea9, content=非常不错的临床经验，值得借鉴与推广，学习了，受益匪浅，谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/27/c53a212859edcad4f60a54feffff50bb.jpg, createdBy=67cf1525321, createdName=13718711b3m, createdTime=Wed Nov 14 09:38:38 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345000, encodeId=b2e834500090, content=Thank foryou , beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/5c6d9ad84d8af7c9d20340af15a39b5a.jpg, createdBy=9a732240675, createdName=徐小坏, createdTime=Fri Sep 14 21:10:16 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341573, encodeId=7add3415e3fb, content=谢谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Aug 29 07:38:56 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2018-11-19 1246deccm12暂无昵称

    请问有中文版的吗？中文版的哪里可以找得到呢？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057560, encodeId=d642105e56034, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:58 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353072, encodeId=13083530e24d, content=请问有中文版的吗？中文版的哪里可以找得到呢？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95442486909, createdName=1246deccm12暂无昵称, createdTime=Mon Nov 19 19:25:40 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352547, encodeId=997135254ea9, content=非常不错的临床经验，值得借鉴与推广，学习了，受益匪浅，谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/27/c53a212859edcad4f60a54feffff50bb.jpg, createdBy=67cf1525321, createdName=13718711b3m, createdTime=Wed Nov 14 09:38:38 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345000, encodeId=b2e834500090, content=Thank foryou , beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/5c6d9ad84d8af7c9d20340af15a39b5a.jpg, createdBy=9a732240675, createdName=徐小坏, createdTime=Fri Sep 14 21:10:16 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341573, encodeId=7add3415e3fb, content=谢谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Aug 29 07:38:56 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2018-11-14 13718711b3m

    非常不错的临床经验，值得借鉴与推广，学习了，受益匪浅，谢谢分享！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1057560, encodeId=d642105e56034, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:58 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353072, encodeId=13083530e24d, content=请问有中文版的吗？中文版的哪里可以找得到呢？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95442486909, createdName=1246deccm12暂无昵称, createdTime=Mon Nov 19 19:25:40 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352547, encodeId=997135254ea9, content=非常不错的临床经验，值得借鉴与推广，学习了，受益匪浅，谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/27/c53a212859edcad4f60a54feffff50bb.jpg, createdBy=67cf1525321, createdName=13718711b3m, createdTime=Wed Nov 14 09:38:38 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345000, encodeId=b2e834500090, content=Thank foryou , beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/5c6d9ad84d8af7c9d20340af15a39b5a.jpg, createdBy=9a732240675, createdName=徐小坏, createdTime=Fri Sep 14 21:10:16 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341573, encodeId=7add3415e3fb, content=谢谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Aug 29 07:38:56 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2018-09-14 徐小坏

    Thank foryou

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1057560, encodeId=d642105e56034, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:58 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353072, encodeId=13083530e24d, content=请问有中文版的吗？中文版的哪里可以找得到呢？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95442486909, createdName=1246deccm12暂无昵称, createdTime=Mon Nov 19 19:25:40 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352547, encodeId=997135254ea9, content=非常不错的临床经验，值得借鉴与推广，学习了，受益匪浅，谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/27/c53a212859edcad4f60a54feffff50bb.jpg, createdBy=67cf1525321, createdName=13718711b3m, createdTime=Wed Nov 14 09:38:38 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345000, encodeId=b2e834500090, content=Thank foryou , beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/5c6d9ad84d8af7c9d20340af15a39b5a.jpg, createdBy=9a732240675, createdName=徐小坏, createdTime=Fri Sep 14 21:10:16 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341573, encodeId=7add3415e3fb, content=谢谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Aug 29 07:38:56 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2018-08-29 明月清辉

    谢谢分享，学习了

    0

相关指南

2018 欧洲联合共识声明：房颤患者表现为急性冠脉综合征和/或经皮心血管介入治疗的抗栓治疗管理

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2018-07-21

2018 EHRA实践指导：房颤患者应用非维生素K拮抗剂口服抗凝药

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2018-03-20

2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2017-11-01

2017 AAFP临床实践指南：新发现房颤的药物治疗（更新版）

美国家庭医师学会(AAFP,American Academy of Family Physicians) · 2017-04-01

2017 HRS/EHRA/ECAS/APHRS/SOLAECE专家共识声明：房颤导管和外科消融

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2017-05-12

2017 AATS专家共识指南：房颤外科消融治疗

美国胸外科协会(AATS,American Association for Thoracic Surgery) · 2017-04-12